Vimarsana
Biggest News Aggregation in the World

Page 5 - Generation Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Generation Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Generation Bio Today - Breaking & Trending Today

Dannielle Appelhans Acquires 12,000 Shares of Generation Bio Co. (NASDAQ:GBIO) Stock - Vimarsana News

Dannielle Appelhans Acquires 12,000 Shares of Generation Bio Co. (NASDAQ:GBIO) Stock

Generation Bio Co. (NASDAQ:GBIO – Get Free Report) Director Dannielle Appelhans purchased 12,000 shares of the firm’s stock in a transaction dated Monday, December 4th. The stock was bought at an average cost of $1.50 per share, for a total transaction of $18,000.00. Following the acquisition, the director now directly owns 12,000 shares in the […]

Director Rowland Charles A Jr Acquires 342,960 Shares of Generation Bio Co (GBIO) - Vimarsana News

Director Rowland Charles A Jr Acquires 342,960 Shares of Generation Bio Co (GBIO)

In a notable insider transaction, Rowland Charles A Jr, a director at Generation Bio Co, has significantly increased his stake in the company.

Source: yahoo.com
Rx Rundown: The FDA, Amgen, Spyre Therapeutics and more - Vimarsana News

Rx Rundown: The FDA, Amgen, Spyre Therapeutics and more

Check out this week’s medical marketing news, people on the move and industry chatter.

Generation Bio cuts workforce by 40 percent - Vimarsana News

Generation Bio cuts workforce by 40 percent

The Cambridge biotech startup is seeking to extend its cash into 2027.

Generation Bio Co. (NASDAQ:GBIO) Receives Consensus Recommendation of "Hold" from Analysts - Vimarsana News

Generation Bio Co. (NASDAQ:GBIO) Receives Consensus Recommendation of "Hold" from Analysts

Generation Bio Co. (NASDAQ:GBIO – Get Free Report) has been given an average rating of “Hold” by the six analysts that are covering the stock, MarketBeat Ratings reports. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month price target among analysts […]